Skip to content
10-K

Annual Report

CATALYST PHARMACEUTICALS, INC. CPRX

0001193125-26-071525

← back to feed
Filed
Feb 25, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Feb 23, 2026 122.12M sh
Shares Diluted FY 2025 · Dec 31, 2025 127.26M sh
Shares Diluted FY 2025 · Dec 31, 2024 124.94M sh
Shares Diluted FY 2025 · Dec 31, 2023 113.75M sh
Stock Repurchased FY 2025 · Dec 31, 2025 $25.3M
Stock Repurchased FY 2025 · Dec 31, 2024 $0
Stock Repurchased FY 2025 · Dec 31, 2023 $0
Capex FY 2025 · Dec 31, 2025 $58K
Capex FY 2025 · Dec 31, 2024 $556K
Capex FY 2025 · Dec 31, 2023 $231K
Operating Cash Flow FY 2025 · Dec 31, 2025 $208.67M
Operating Cash Flow FY 2025 · Dec 31, 2024 $239.81M
Operating Cash Flow FY 2025 · Dec 31, 2023 $143.6M
Cash And Equivalents FY 2025 · Dec 31, 2025 $709.17M
Cash And Equivalents FY 2025 · Dec 31, 2024 $517.55M
Stockholders Equity FY 2025 · Dec 31, 2025 $954.27M
Stockholders Equity FY 2025 · Dec 31, 2024 $727.63M
Stockholders Equity FY 2025 · Dec 31, 2023 $387.88M
Stockholders Equity FY 2025 · Dec 31, 2022 $300.42M
Current Liabilities FY 2025 · Dec 31, 2025 $147.15M
Current Liabilities FY 2025 · Dec 31, 2024 $120.68M
Total Liabilities FY 2025 · Dec 31, 2025 $149.71M
Total Liabilities FY 2025 · Dec 31, 2024 $123.78M
Current Assets FY 2025 · Dec 31, 2025 $894.03M
Current Assets FY 2025 · Dec 31, 2024 $623.61M
Total Assets FY 2025 · Dec 31, 2025 $1.1B
Total Assets FY 2025 · Dec 31, 2024 $851.41M
Eps Diluted FY 2025 · Dec 31, 2025 $1.68
Eps Diluted FY 2025 · Dec 31, 2024 $1.31
Eps Diluted FY 2025 · Dec 31, 2023 $0.63
Eps Basic FY 2025 · Dec 31, 2025 $1.75
Eps Basic FY 2025 · Dec 31, 2024 $1.38
Eps Basic FY 2025 · Dec 31, 2023 $0.67
Sga Expense FY 2025 · Dec 31, 2025 $193.75M
Sga Expense FY 2025 · Dec 31, 2024 $177.74M
Sga Expense FY 2025 · Dec 31, 2023 $133.71M
Rd Expense FY 2025 · Dec 31, 2025 $12.71M
Rd Expense FY 2025 · Dec 31, 2024 $12.65M
Rd Expense FY 2025 · Dec 31, 2023 $93.15M
Operating Income FY 2025 · Dec 31, 2025 $257.78M
Operating Income FY 2025 · Dec 31, 2024 $195.12M
Operating Income FY 2025 · Dec 31, 2023 $86.81M
Revenue FY 2025 · Dec 31, 2025 $588.99M
Revenue FY 2025 · Dec 31, 2024 $491.73M
Revenue FY 2025 · Dec 31, 2023 $398.2M